Alpha-linolenic acid confers protection on mice renal cells against cisplatin-induced nephrotoxicity

被引:0
作者
Erman Salih İstifli
Erkan Demir
Halil Mahir Kaplan
Kıvılcım Eren Ateş
Figen Doran
机构
[1] Cukurova University,Department of Biology, Faculty of Science and Letter
[2] Cukurova University,Department of Urology, Faculty of Medicine
[3] Cukurova University,Department of Pharmacology, Faculty of Medicine
[4] Cukurova University,Department of Pathology, Faculty of Medicine
来源
Cytotechnology | 2019年 / 71卷
关键词
Alpha-Linolenic acid; Cisplatin; Oxidative stress; Nephrotoxicity;
D O I
暂无
中图分类号
学科分类号
摘要
Cisplatin is an antineoplastic agent used in the treatment of various types of solid tumors. Despite the dose-dependency of its antineoplastic effect, the high risk for nephrotoxicity frequently precludes the use of higher doses. α-Linolenic acid (ALA), a carboxylic acid having three cis double bonds, is an essential fatty acid required for health and can be acquired via foods that contain ALA or supplementation of foods high in ALA. Previous studies have shown that ALA demonstrates anti-cancer, anti-inflammatory, and anti-oxidative effects. In this study, we show the protective effect of ALA on cisplatin-induced renal toxicity associated with oxidative stress in mice using biochemical parameters. The mice were randomly assigned into four experimental groups. Group 1 (control group) were administered physiological saline solution for 9 days; group 2 (ALA group) received 200 mg/kg alpha-linolenic acid via gavage for 9 days; group 3 (CIS group) received 100 mg/kg intraperitoneal (i.p.) CIS for 9 days; and group 4 (ALA + CIS group) received 100 mg/kg i.p. CIS and followed by ALA 200 mg/kg via gavage for 9 days. Alpha-linolenic acid significantly reduced the expression of myeloperoxidase (MPO), phospholipase A2 (PLA2), cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in the ALA + CIS group compared to the CIS group. Furthermore, catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx) quantities were significantly elevated in the ALA + CIS group when compared to the CIS group. ALA significantly decreased the levels of Bax and cleaved caspase-3, while significantly increasing the level of bcl-2, an anti-apoptotic protein, in the ALA + CIS group than in the CIS group. Finally, histopathological examination in renal tissue showed that the significant edematous damage induced by CIS administration alone was reduced in ALA + CIS group. In conclusion, our findings show that ALA is beneficial to CIS-induced nephrotoxicity in mice via its anti-inflammatory and anti-oxidative effects.
引用
收藏
页码:905 / 914
页数:9
相关论文
共 157 条
[1]  
Calder PC(2013)Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol 75 645-662
[2]  
Camuesco D(2005)Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis J Nutr 135 687-694
[3]  
Galvez J(2016)α-Linolenic acid reduces TNF-induced apoptosis in C2C12 myoblasts by regulating expression of apoptotic proteins Eur J Transl Myol 26 6033-242
[4]  
Nieto A(2009)Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity Exp Toxicol Pathol 61 223-378
[5]  
Comalada M(2014)Cisplatin in cancer therapy: molecular mechanisms of action Eur J Pharmacol 740 364-909
[6]  
Rodriguez-Cabezas ME(2007)The role of nitric oxide synthases in lung inflammation Curr Opin Invest Dr 8 899-1371
[7]  
Concha A(2011)Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects Cancers 3 1351-366
[8]  
Xaus J(2012)The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder J Affect Disord 138 360-175
[9]  
Zarzuelo A(2018)Alpha linolenic acid decreases apoptosis and oxidized phospholipids in cardiomyocytes during ischemia/reperfusion Mol Cell Biochem 437 163-869
[10]  
Carotenuto F(1999)Platinum organ toxicity and possible prevention in patients with testicular cancer Int J Cancer 83 866-1721